PHILADELPHIA (December 18, 2023) — Fox Chase Cancer Center recently welcomed over 200 friends and supporters to the Franklin Institute in Philadelphia for a panel presentation, “A Serious Conversation About Cancer,” which focused on some of the latest developments in cancer research and treatment by top oncology leaders.
To present the event, Fox Chase partnered with the Damon Runyon Cancer Research Foundation, an organization whose mission is to support young scientists who are pursuing high-risk, high-reward research focused on all types of cancers.
View a full recording of the panel presentation from this event on Fox Chase’s YouTube channel.
“Opportunities such as this allow us to showcase the mission and work of our institution in a very unique way. When someone asks me what we do at Fox Chase, I tell them we discover and we deliver. We discover new ways to deliver better care. I’m proud to show that through our history that is what we’ve done,” said Robert Uzzo, MD, MBA, FACS, President and CEO of Fox Chase and the G. Willing “Wing” Pepper Chair in Cancer Research.
“We don’t focus on any particular cancer type because we know that an understanding of the fundamental mechanisms that change in cells that can give rise to disease is incredibly important for understanding cancer, how it develops, and developing better treatment and diagnoses,” said Yung S. Lie, PhD, president and CEO of the Damon Runyon Cancer Research Foundation and a former Damon Runyon Fellow.
The event was hosted by David Marshall, a foundation board member and a board member of the Fox Chase Board of Directors as well as the Vice Chair of Investments and Treasurer of the Damon Runyan Cancer Research Foundation Board of Directors, and his wife Sandy Marshall. The 90-minute event included a question and answer session.
The discussion highlighted topics ranging from advances in machine learning and genomics to the application of personalized medicine. After the formal panel discussion, attendees were able to speak directly with cancer experts in Franklin Hall.
In addition to Lie and Uzzo, the panel discussion featured several other experts:
- Jonathan Chernoff, MD, PhD, Fox Chase Cancer Center Director and the Stanley P. Reimann Chair in Oncology Research;
- William G. Kaelin Jr., MD, Sidney Farber Professor of Medicine at the Dana-Farber Cancer Institute and Harvard Medical School, a Damon Runyon board member, and the 2019 recipient of the Nobel Prize in Physiology or Medicine;
- and Jennifer M. Kalish, MD, PhD, the Lorenzo “Turtle” Sartini Jr. Endowed Chair in Beckwith-Wiedemann Syndrome Research at Children’s Hospital of Philadelphia and a Damon Runyon Clinical Investigator.
All proceeds from the event will support cancer research being conducted by investigators at Fox Chase and the Damon Runyon Cancer Research Foundation.